|
VIPAR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.566200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.700000E-01 |
| Normal-vs-Stage2 |
5.399400E-01 |
| Normal-vs-Stage3 |
6.712400E-01 |
| Normal-vs-Stage4 |
2.176000E-01 |
| Stage1-vs-Stage2 |
9.064200E-01 |
| Stage1-vs-Stage3 |
5.630600E-01 |
| Stage1-vs-Stage4 |
5.703400E-01 |
| Stage2-vs-Stage3 |
7.698000E-01 |
| Stage2-vs-Stage4 |
5.601200E-01 |
| Stage3-vs-Stage4 |
3.309200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.978000E-01 |
| Normal-vs-AfricanAmerican |
5.269700E-02 |
| Normal-vs-Asian |
1.851220E-01 |
| Caucasian-vs-AfricanAmerican |
7.354400E-02 |
| Caucasian-vs-Asian |
3.429600E-01 |
| AfricanAmerican-vs-Asian |
3.055000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.719970E-01 |
| Normal-vs-Female |
4.991200E-01 |
| Male-vs-Female |
2.261000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.418600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.846800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.538200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.117400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.790800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.229600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.061400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.319000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.888780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.491600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.458800E-01 |
| Classical-VS-Follicular |
8.066000E-02 |
| Classical-VS-Other |
7.987800E-01 |
| Classical-VS-Normal |
1.231350E-01 |
| Tall-VS-Follicular |
5.939600E-01 |
| Tall-VS-Other |
6.271000E-01 |
| Tall-VS-Normal |
6.831000E-01 |
| Follicular-VS-Other |
4.004800E-01 |
| Follicular-VS-Normal |
9.369200E-01 |
| Other-VS-Normal |
3.878600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.776800E-01 |
| Normal-vs-N1 |
5.577000E-01 |
| N0-vs-N1 |
2.017200E-01 |
|
|
